Transfer factor therapy in a patient with progressive primary tuberculosis.
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000209:etiology; D002464:Cell Migration Inhibition; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007538:Isoniazid / Q000627:therapeutic use; D037102:Lectins / Q000494:pharmacology; D008214:Lymphocytes / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D011718:Pyrazinamide / Q000627:therapeutic use; D011859:Radiography; D012293:Rifampin / Q000627:therapeutic use; D013156:Splenectomy; D013299:Streptodornase and Streptokinase / Q000494:pharmacology; D013307:Streptomycin / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014374:Tuberculin Test; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000276:immunology / Q000628:therapy*
D000636:Aminosalicylic Acids; D037102:Lectins; D014316:Tritium; D011718:Pyrazinamide; D004977:Ethambutol; D013299:Streptodornase and Streptokinase; D007538:Isoniazid; D013936:Thymidine; D012293:Rifampin; D013307:Streptomycin